SLC25A13 and Hypoglycemia: Patients with citrin deficiency exhibit a MAS disruption affecting metabolic pathways including glycolysis, gluconeogenesis (GNEO), lipid metabolism and the TCA cycle, resulting in hypoglycemia, dyslipidemia, hepatic steatosis and an energy deficit (43).